A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
Medtronic has announced it will acquire China Kanghui Holdings for $816 million. Kanghui Holdings is a maker of orthopedic devices. The transaction is expected to close in the next few months. Becker’s ASC Review